These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 15374171)
61. A multicenter, randomized, double-blind clinical trial comparing the low-density lipoprotein cholesterol-lowering ability of lovastatin 10, 20, and 40 mg/d with fluvastatin 20 and 40 mg/d. Davidson MH; Palmisano J; Wilson H; Liss C; Dicklin MR Clin Ther; 2003 Nov; 25(11):2738-53. PubMed ID: 14693301 [TBL] [Abstract][Full Text] [Related]
62. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice. Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658 [TBL] [Abstract][Full Text] [Related]
63. Cholesteryl ester transfer activity in liver disease and cholestasis, and its relation with fatty acid composition of lipoprotein lipids. Iglesias A; Arranz M; Alvarez JJ; Perales J; Villar J; Herrera E; Lasunción MA Clin Chim Acta; 1996 Apr; 248(2):157-74. PubMed ID: 8740580 [TBL] [Abstract][Full Text] [Related]
64. Efficacy and tolerability of lovastatin in hypercholesterolemic women. D'Agostino RB; Kannel WB; Stepanians MN; D'Agostino LC Clin Ther; 1992; 14(3):390-5. PubMed ID: 1638580 [TBL] [Abstract][Full Text] [Related]
65. Lovastatin therapy in receptor-negative homozygous familial hypercholesterolemia: lack of effect on low-density lipoprotein concentrations or turnover. Uauy R; Vega GL; Grundy SM; Bilheimer DM J Pediatr; 1988 Aug; 113(2):387-92. PubMed ID: 3397806 [TBL] [Abstract][Full Text] [Related]
66. Combination drug therapy for familial combined hyperlipidemia. East C; Bilheimer DW; Grundy SM Ann Intern Med; 1988 Jul; 109(1):25-32. PubMed ID: 3288029 [TBL] [Abstract][Full Text] [Related]
67. The efficacy of intensive dietary therapy alone or combined with lovastatin in outpatients with hypercholesterolemia. Hunninghake DB; Stein EA; Dujovne CA; Harris WS; Feldman EB; Miller VT; Tobert JA; Laskarzewski PM; Quiter E; Held J N Engl J Med; 1993 Apr; 328(17):1213-9. PubMed ID: 8464431 [TBL] [Abstract][Full Text] [Related]
68. The effect of aggressive and moderate lowering of LDL-cholesterol and low dose anticoagulation on plasma lipids, apolipoproteins and lipoprotein families in post coronary artery bypass graft trial. Alaupovic P; Fesmire JD; Hunnighake D; Domanski M; Forman S; Knatterud GL; Forrester J; Herd JA; Hoogwerf B; Campeau L; Gobel FL Atherosclerosis; 1999 Oct; 146(2):369-79. PubMed ID: 10532693 [TBL] [Abstract][Full Text] [Related]
69. Comparison of lovastatin and gemfibrozil in normolipidemic patients with hypoalphalipoproteinemia. Vega GL; Grundy SM JAMA; 1989 Dec; 262(22):3148-53. PubMed ID: 2810673 [TBL] [Abstract][Full Text] [Related]
70. Effects of policosanol and lovastatin on lipid profile and lipid peroxidation in patients with dyslipidemia associated with type 2 diabetes mellitus. Castaño G; Menéndez R; Más R; Amor A; Fernández JL; González RL; Lezcay M; Alvarez E Int J Clin Pharmacol Res; 2002; 22(3-4):89-99. PubMed ID: 12837046 [TBL] [Abstract][Full Text] [Related]
71. Garlic powder, effect on plasma lipids, postprandial lipemia, low-density lipoprotein particle size, high-density lipoprotein subclass distribution and lipoprotein(a). Superko HR; Krauss RM J Am Coll Cardiol; 2000 Feb; 35(2):321-6. PubMed ID: 10676676 [TBL] [Abstract][Full Text] [Related]
72. Effect of combining viscous fibre with lovastatin on serum lipids in normal human subjects. Agrawal AR; Tandon M; Sharma PL Int J Clin Pract; 2007 Nov; 61(11):1812-8. PubMed ID: 17935545 [TBL] [Abstract][Full Text] [Related]
73. Efficacy and tolerability of lovastatin in 3390 women with moderate hypercholesterolemia. Bradford RH; Downton M; Chremos AN; Langendörfer A; Stinnett S; Nash DT; Mantell G; Shear CL Ann Intern Med; 1993 Jun; 118(11):850-5. PubMed ID: 8480959 [TBL] [Abstract][Full Text] [Related]
74. Effect of lovastatin on serum lipid profile in the treatment of dyslipoproteinaemia in uraemic patients on continuous ambulatory peritoneal dialysis. Li PK; Mak TW; Chiu K; Mak GY; Leung CB; Lui SF; Lam CW; Lai KN Aust N Z J Med; 1993 Jun; 23(3):252-7. PubMed ID: 8352699 [TBL] [Abstract][Full Text] [Related]
75. [The effect of lovastatin in the treatment of primary hypercholesterolemia]. Chi JM; Li LS; Sun MZ Zhonghua Nei Ke Za Zhi; 1992 Jan; 31(1):32-4, 61. PubMed ID: 1395911 [TBL] [Abstract][Full Text] [Related]
76. Comparative effects of lovastatin and niacin in primary hypercholesterolemia. A prospective trial. Illingworth DR; Stein EA; Mitchel YB; Dujovne CA; Frost PH; Knopp RH; Tun P; Zupkis RV; Greguski RA Arch Intern Med; 1994 Jul; 154(14):1586-95. PubMed ID: 8031206 [TBL] [Abstract][Full Text] [Related]
77. [Personal experience with lovastatin, a HMG-CoA reductase inhibitor (Mevacor, MSD) in the treatment of hypercholesterolemia]. Vaverková H; Skottová N; Pudilová L; Horcicka V; Jezdinský J; Trtková M Vnitr Lek; 1991 May; 37(5):463-9. PubMed ID: 1842144 [TBL] [Abstract][Full Text] [Related]
78. [Effect of combined treatment with lovastatin and colestipol on serum lipids and lipoproteins]. Kłosiewicz-Latoszek L; Nowicka G; Szostak WB Wiad Lek; 1993 Aug; 46(15-16):581-5. PubMed ID: 7975581 [TBL] [Abstract][Full Text] [Related]
79. Lipid and antioxidant blood levels in vegetarians. Krajcovicová-Kudlácková M; Simoncic R; Béderová A; Klvanová J; Brtková A; Grancicová E Nahrung; 1996 Feb; 40(1):17-20. PubMed ID: 8975140 [TBL] [Abstract][Full Text] [Related]